Replies to post #20681 on Mymetics Corp (MYMX)

[Work Harder]

VFI

MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

https://www.emdgroup.com/en/news/transvac2-program-joining-20-05-2019.html

Our mission: supporting the vaccine community with adjuvant and formulation expertise on an open access basis

https://www.vformulation.org/

VFI, a not-for-profit company based in Switzerland, is dedicated to provide its technologies in open-access to all interested groups.

https://www.vformulation.org/news/

VFI supports Sars-Cov-2 vaccine development through TRANSVAC2 (European Commission)

VFI supports Sars-Cov-2 vaccine development through GH-VAP (Bill & Melinda Gates Foundation)

1. March 2020

VFI is working with grantees from the Bill & Melinda Gates Foundation (BMGF) to evaluate Sars-Cov-2 vaccine candidates. Antigens provided by BMGF grantees are appropriately formulated with adjuvants developed by VFI with the ultimate goal to identify suitable Sars-Cov-2 vaccine candidates which can progress towards the clinic. This work is supported by the Global Health Vaccine …


VFI and Merck provide vaccine process development training courses within TRANSVAC2


https://www.airliquide.com/healthcare/healthcare-specialty-ingredients#:~:text=As%20a%20subsidiary%20of%20Air,markets%20for%20over%2060%20years.

[Phosphene]

John A Robinson is Virometix cofounder and president.

Your post shows him working with Mario.

Gerd Pluschke also on Virometix patents with Arin Ghasparian (also Virometix CEO and cofounder):

https://patents.justia.com/inventor/arin-ghasparian

https://tracxn.com/d/companies/virometix.com

https://www.firstwordpharma.com/node/1739350?tsid=33